INDUSTRY
The healthcare landscape is shifting. Discover how we're helping companies deliver better patient outcomes.
Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes. For those ready to seize the opportunity, it’s creating infinite new possibilities to reinvent the patient experience and redefine the future of healthcare.
Accenture is working with our pharmaceutical, biotech, medical technology, distributor and consumer health clients around the world every day to make that happen. See how we’re helping our clients combine the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.
The Accenture Life Sciences practice offers a full range of services that set the gold standard for personalized, intuitive and integrated healthcare.
See how Biogen and Accenture used quantum computing to improve drug discovery.
See how we partnered to remove barriers to treatment through mobile technology.
Saving lives and improving the health and well-being of mothers during pregnancy and childbirth
Read how Artificial Intelligence can drive growth and sustainability on the commercial side of the life sciences industry.
Alessandro de Luca, the Chief Information Officer at Merck Healthcare of the Merck Group discusses the impact of AI Life Sciences.
Read how our 3 Technology Vision trends can have a positive effect on the patient experience.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
Recognized by Frost & Sullivan
2018 Recipient
Recognized by IDC MarketScape
2018 Recognition
Recogized by Everest Group
2017 Recipient
We are proud to collaborate with leading women in life sciences in their quest to advance science and patient care.
Yoko Saiki is the Executive Director of Strategic Business Management – Japan Sales & Marketing at Astellas Pharma. After joining Astellas Pharma in 2009, she had a role in strategic planning as well as the formulation of the company’s code of conduct, the "Astellas Way". Learn more about Yoko's journey in life sciences and the advice she has for the next generation.
Managing Director, Asia Pacific Lead – Life Sciences
Managing Director, Supply Chain Global and NA Lead – Life Sciences
Managing Director, Japan Lead – Life Sciences
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Kevin Julian discusses how to make the most of AI in biopharmaceutical R&D.
Floren Robinson Pressman examines how AI is poised to revolutionize the commercial side of the life sciences industry.
The adoption of a unique combination of the best in science and health technology are expected to be the biopharma industry’s new growth machine.
Acquisition will strengthen Accenture’s capabilities to transform manufacturing for pharmaceutical, biotech and medical device clients globally.
